Production (Stage)
Zenas BioPharma, Inc.
ZBIO
$11.43
-$0.02-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.94% | -9.32% | 110.30% | 395.05% | -34.65% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.55% | -56.05% | 101.12% | 123.73% | -5.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.71% | -9.61% | 108.79% | 375.00% | -33.61% |
|
|
|||||
| Total Current Assets | -10.71% | -9.61% | 108.79% | 375.00% | -33.61% |
| Net Property, Plant & Equipment | 7.32% | 118.17% | -22.80% | -16.65% | -16.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.06% | 41.14% | -14.44% | 25.26% | 15.44% |
| Total Assets | -9.79% | -8.29% | 101.76% | 307.64% | -28.06% |
|
|
|||||
| Total Accounts Payable | 16.82% | 13.62% | 80.45% | -3.15% | 59.93% |
| Total Accrued Expenses | -27.99% | 37.25% | -4.02% | 53.34% | 14.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.67% | 104.43% | -22.27% | -4.26% | -7.19% |
| Total Finance Division Other Current Liabilities | -97.63% | -- | -- | -70.57% | 498.34% |
| Total Other Current Liabilities | -97.63% | -- | -- | -70.57% | 498.34% |
| Total Current Liabilities | -14.24% | 30.22% | 12.50% | 28.93% | 30.42% |
|
|
|||||
| Total Current Liabilities | -14.24% | 30.22% | 12.50% | 28.93% | 30.42% |
| Long-Term Debt | -- | -- | -- | -- | 3.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 45.41% | -- | -- | -89.47% | -48.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -14.02% | 30.71% | 12.46% | -23.98% | 17.45% |
|
|
|||||
| Common Stock & APIC | 0.78% | 0.79% | 9,416.96% | 29.46% | 21.29% |
| Retained Earnings | -8.67% | -15.71% | -13.03% | -14.71% | -12.07% |
| Treasury Stock & Other | -27.32% | 259.26% | -48.08% | 40.54% | 100.00% |
| Total Common Equity | -9.01% | -13.07% | 224.47% | -14.37% | -11.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 79.78% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 79.78% | 0.00% |
|
|
|||||
| Total Common Equity | -9.01% | -13.07% | 224.47% | -14.37% | -11.86% |
| Total Preferred Equity | -- | -- | -- | 79.78% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.01% | -13.07% | 123.49% | 6,776.21% | -109.89% |
|
|
|||||